PR Newswire | Jan 22, 2021 01:41AM EST

01/22 00:40 CST

Elekta divests its stake in ViewRay STOCKHOLM, Jan. 22, 2021

STOCKHOLM, Jan. 22, 2021 /PRNewswire/ -- Elekta AB (EKTA-B.ST) announced today that it has sold its 7.3 percent of the outstanding common stock (11,501,597 shares) in ViewRay, Inc. (Nasdaq:VRAY). Elekta has no remaining shares in ViewRay after the transaction.

The shares in ViewRay were purchased in a public offering in December 2019 at USD 3.13 per share and sold today at USD 4.65 per share. The proceeds from the sale were approximately USD 53 million, resulting in a gain of approximately USD 17.5 million. The gain will be booked in Elekta's third quarter 2020/21.

For further information, please contact: Mattias Thorsson, VP Corporate CommunicationsTel: +46 70 865 8012e-mail: Mattias.Thorsson@elekta.comTime zone: CET: Central European Time Cecilia Ketels, Head of Investor RelationsTel: +46 76 611 76 25e-mail: cecilia.ketels@elekta.com Time zone: CET: Central European Time This is information that Elekta AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 07:30 CET on January 22, 2021. (REGMAR) About Elekta For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter. This information was brought to you by Cision http://news.cision.com https://news.cision.com/elekta/r/elekta-divests-its-stake-in-viewray,c3272256 The following files are available for download: https://mb.cision.com/Main/35/3272256/1362202.pdf Release

View original content: http://www.prnewswire.com/news-releases/elekta-divests-its-stake-in-viewray-301213035.html

SOURCE Elekta